PTCT
PTC Therapeutics Inc
62.30$
-5.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -249.4% | -338.2% | -125.2% | -5.2% | -10.4% | -32.1% | -51.0% | -46.7% | -51.0% | -16.9% | -13.3% | 41.1% | |
| 9.7% | 7.8% | 4.0% | 9.1% | 9.9% | 10.5% | 22.3% | 11.9% | 18.4% | 25.2% | 9.4% | 2.2% | |
| 84.1% | 92.4% | 42.3% | 15.7% | 12.6% | 13.7% | 18.5% | 19.2% | 15.8% | 14.0% | 9.2% | 4.3% | |
| 91.7% | 97.8% | 50.8% | 19.1% | 22.7% | 31.9% | 17.1% | 42.8% | 16.3% | – | – | – | |
| 57.5% | 12.8% | -10.8% | 6.8% | 5.4% | 6.7% | 9.7% | -4.4% | -12.2% | -0.4% | 12.7% | -2.8% | |
| 20.3% | 7.4% | 2.1% | 1.6% | 5.9% | 14.8% | 14.7% | 15.8% | 21.8% | 12.9% | 9.2% | 17.3% | |
| -632.2% | -56.6% | 126.3% | 6.7% | -16.1% | -126.1% | -147.5% | 40.7% | 41.5% | -18.8% | 5.5% | -49.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 1,027.6% | 23.7% | 1.2% | 1.1% | 49.7% | 112.6% | 27.2% | 4.3% | 10.2% | – | – | – | |
| -0.2% | 395.3% | 48.4% | -0.2% | 101.1% | 87.2% | -7.6% | -0.4% | 19.8% | -32.1% | -0.2% | -0.1% | |
| 1,032.6% | 419.0% | 1.2% | 22.7% | 49.7% | 199.8% | 175.6% | 3.9% | 24.0% | 68.9% | 31.7% | 19.1% | |
| 149.5% | 22.5% | 0.4% | 27.5% | 21.8% | 41.1% | -20.8% | -3.5% | 14.1% | 33.5% | 22.9% | 11.7% | |
| -269.7% | -345.6% | -127.4% | -6.8% | -16.3% | -46.9% | -65.7% | -62.5% | -72.9% | -29.8% | -22.6% | 23.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.